UNSPSC 41106309: Premade complementary deoxyribonucleic acid cDNA

UNSPSC 41106309 Premade complementary deoxyribonucleic acid cDNA is a Commodity code under which state and local forensic laboratories, public health agencies, and criminal justice departments procure specialized DNA analysis consumables and reagents for human identification, genetic analysis, newborn screening, and controlled-substance testing. Recent solicitations show state and local buyers acquiring RapidHIT system cartridges and sample kits, Life Technologies genetic analyzer components and sequencing kits, DNA quantification and size standards, DNA extraction reagents for screening programs, and associated laboratory consumables—often single-source or proprietary procurements tied to specific DNA analysis platforms already deployed in evidence-processing workflows. The buying bodies include state forensic services divisions, departments of public safety, health and human services commissions, and criminal justice laboratories across multiple states. Forensic applications dominate the recent activity, with procurements supporting casework processing, human identification for criminal investigations, and population screening programs for communicable disease detection and genetic disorder identification.

Texas leads recent procurement activity under the code, with the Texas Comptroller of Public Accounts Statewide Procurement Division, Texas Department of Public Safety, Texas Health and Human Services Commission, and Texas Department of Parks and Wildlife all issuing solicitations. The Texas Comptroller issued IFB 304T-27-175A1.1 (due October 20, 2026) for proprietary chemical laboratory equipment and supplies spanning DNA analysis consumables, forensic reagents, and drug-screening kits from Life Technologies, Promega, Qiagen, Immunalysis, and ANDE Corporation, serving statewide delivery with a four-year contract term and renewal options. The Texas Department of Public Safety issued IFB 405-26R0017287 (due July 22, 2026) for RapidHIT consumables including sample kits, primary and utility cartridges, and control cartridges for the Crime Lab at 5800 Guadalupe, Austin. The Texas Health and Human Services Commission issued IFB HHS0017640 (due July 15, 2026) for QuantaBio DNA extraction reagents for newborn screening of Severe Combined Immunodeficiency Disorder and Spinal Muscular Atrophy, with estimated annual spend of $2.5 million and a contract term from September 1, 2026 through August 31, 2031 with optional renewals. The Illinois State Police Forensic Services Division executed an emergency sole-source procurement for repair services to inoperable thermal cycler units (August 21, 2026, $7,900 estimated value) through Remi Holdings, LLC. The Mississippi Forensic Laboratory issued RFI 1711-26-R-RFIN-00013 (due July 21, 2026) for Life Technologies kits and reagents under proprietary-product constraints.